(CNN) — The interim CEO and director of drugmaker Kenvue, which makes the common pain reliever Tylenol, met with US Health and Human Services Secretary Robert F. Kennedy Jr. privately this week in an attempt to dissuade him from including the drug as a potential cause of autism in an upcoming report, the Wall Street Journal reported Friday.

HHS officials have announced that the department is conducting a study of the causes of autism, and recent reports suggest that HHS will issue an analysis that links the development of autism to the mother’s use of Tylenol during pregnancy, among other potential causes. The report is expected to be released this month.

Tylenol is a brand name for the pain reliever acetaminophen.

The American College of Obstetricians and Gynecologists has said that th

See Full Page